Ignite Creation Date:
2025-12-24 @ 3:53 PM
Ignite Modification Date:
2025-12-30 @ 7:08 AM
Study NCT ID:
NCT01427192
Status:
COMPLETED
Last Update Posted:
2012-12-12
First Post:
2011-01-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Treatment of Sleep Related Breathing Disorders in Patients With Pulmonary Hypertension
Sponsor:
University of Zurich
Organization:
Study Overview
Official Title:
Treatment of Sleep Related Breathing Disorders in Patients With Pulmonary Hypertension (CSRPH)
Status:
COMPLETED
Status Verified Date:
2011-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
CSRPH
Brief Summary:
The purpose of this study is to study the differential short-term effect of nocturnal oxygen, acetazolamide tablets and nocturnal non-invasive positive pressure ventilation on symptoms, exercise capacity and nocturnal breathing disturbances in subjects with pulmonary hypertension and sleep related breathing disorders
* Trial with medicinal product
* Trial with medicinal product
Detailed Description:
None
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: